X
Aug 30, 2022 05:13 PM (GMT+8) · EqualOcean
Luca Healthcare completed the pre-Series A financing round worth tens of millions of CNY. This round of financing was led by Lightspeed China Partners (Chinese: 光速中国), followed by Jinding Capital (Chinese: 金鼎资本) and Picus capital. Founded in 2020, Luca Healthcare focuses on digital biomarker development. The main application scenarios of digital biomarkers include drug efficacy evaluation, digital combination products and digital therapeutics. The company has successfully developed more than 40 digital biomarkers, mainly focusing on respiratory, neuromotor and cognitive areas. Four of its related products are applying for class II and class III medical device registration certificates. Its competitor includes Koneksa, VivoSense and Medable.

Source: